Purchase of Cell Culture Rabies Vaccine Ready to Fill Bulk

The National Institutes of Health (NIH) Islamabad is procuring Cell Culture Rabies Vaccine Ready to Fill Bulk for the fiscal year 2026-27. This procurement is critical for ensuring the availability of rabies vaccine in bulk form for further processing and distribution. The procurement is being conducted under the Least Cost Based Selection (LCBS) method in accordance with Public Procurement Rules, 2004. Items being procured: - Cell Culture Rabies Vaccine Ready to Fill Bulk The scope involves supply of the vaccine in bulk form, ready for filling, meeting all quality and regulatory standards required by the NIH. The procurement will be managed through the e-Pak Acquisition and Disposal System (EPADS) v2.0, ensuring transparency and compliance with government procurement policies. Eligible bidders must be registered on EPADS v2.0 and comply with all bid security requirements such as Pay Order, Call Deposit, or Demand Draft as specified in the bidding documents. Bidders should have relevant experience in supplying vaccines or similar pharmaceutical products and must be registered with FBR and on the Active Taxpayers List (ATL). The tender submission deadline is Tuesday, July 28, 2026, by 11:00 AM via EPADS v2.0, with bid opening scheduled for 11:30 AM the same day. Manual submissions will not be entertained. Interested suppliers are advised to carefully review the bidding documents available on EPADS and ensure timely registration and submission. A practical tip for bidders: Ensure your EPADS registration is complete well before the deadline and prepare your bid security documents in the exact format required to avoid disqualification. Early submission is recommended to handle any technical issues with the online system.